Perharidines as CDK inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8450342
APP PUB NO 20100280065A1
SERIAL NO

12709222

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to trisubstituted or tetrasubstituted imidazo[4,5b]pyridines, to their uses as well as to a process for manufacturing them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE DE RENNES 1RENNES RENNES ILLE-ET-VILAINE
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75794 PARIS CEDEX 16
UNIVERSITE PARIS DESCARTES12 RUE DE L'ECOLE DE MÉDECINE PARIS 75006

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bettayeb, Karima Roscoff, FR 3 10
Demange, Luc Paris, FR 5 62
Galons, Herve Paris, FR 8 29
Meijer, Laurent Roscoff, FR 39 288
Oumata, Nassima Paris, FR 7 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 28, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00